Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria

Final draft guidance

Public committee slides (PDF 994 KB)

Committee papers (PDF 1.2 MB)

Final draft guidance (PDF 307 KB)

Draft guidance

Draft guidance (PDF version) (PDF 305 KB)

Committee papers (PDF 7.14 MB)

Public committee slides (PDF 665 KB)

Equality impact assessment (PDF 148 KB)

Final scope (PDF 172 KB)

Final stakeholder list (PDF 156 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 284 KB)